Ignace Vergote und Ovarian - Info zur Person

(1 - 25 von 28

)

Ignace Vergote, Novocure Clinical Trial Investigatorwww.novocure.com › Stories

www.novocure.com

Oct 19, · Professor Ignace Vergote conducts 20 ovarian cancer trials per year and has authored more than 800 papers in gynecologic cancers.Missing: Börm Bruckmeier" Oct 19, · Professor Ignace Vergote conducts 20 ovarian cancer trials per year and has authored more than 800 papers in gynecologic cancers. Missing: Börm Bruckmeier"

Turabian - AboutScience

journals.aboutscience.eu

Garbi, Annalisa, Maria Teresa Achilarre, Maria Cristina Petrella, Els Van Nieuwenhuysen, and Ignace Vergote. “Case 2 – Advanced Low-Grade Ovarian Cancer ... › get

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC ...

www.nejm.org

von I Vergote · · Zitiert von: — Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. List of authors. Ignace Vergote, M.D., Ph.D.,; Claes G. Tropé, ... › doi › full

Dendritic cell-based immunotherapy in ovarian cancer

www.tandfonline.com

von A Coosemans · · Zitiert von: 17 — An Coosemans is a postdoctoral research fellow supported by the FWO-V; Ignace Vergote and Stefaan W Van Gool are senior clinical investigators supported by ... › onci

Standard of care in for patients with ovarian cancer in ...

biblio.ugent.be

von I Vergote · — Ignace Vergote, Hannelore Denys (UGent) , Jacques De Grève, Christine Gennigens, Koen Van de Vijver (UGent) , Joseph Kerger, Peter Vuylsteke ... › publication

Psychiatric Times

www.psychiatrictimes.com

Primary debulking surgery by a gynecologic oncologist remains the standard of care in advanced ovarian cancer. Optimal debulking surgery should be defined ...

Least Squares Support Vector Machines - Johan A. K. Suykens, Tony Van...

books.google.de

... detection of ovarian cancer (with Chuan Lu, and Dirk Timmerman, Ignace Vergote (K.U. Leuven Hospitals)) and prediction of mental development of preterm ...

Neoadjuvant chemotherapy in advanced ovarian cancer

www.gynecologiconcology-online.net

Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists? Ignace Vergote. › ...

Presentazione standard di PowerPoint - InfoMedics

www.infomedics.it

Neoadjuvant Chemotherapy or Primary Surgery in. Stage IIIC or IV Ovarian Cancer. Ignace Vergote, M.D., Ph.D., Claes G. Tropé, M.D., Ph.D. › italy › documents › pdf

presentation-tarceva-eortc-asco pdf - ARCAGY

arcagy.org

PRESENTED BY: Ignace Vergote. Ovarian, tubal or peritoneal cancer. FIGO stage high-risk I or II-IV (n = 835). 6 – 9 courses platin-based chemotherapy. › files › espace-recherche-pdf

The role of interval debulking surgery in ovarian cancer

link.springer.com

von MEL van der Burg · · Zitiert von: 49 — Maria E. L. van der Burg MD, PhD &; Ignace Vergote MD, PhD. Current Oncology Reports volume 5, pages 473–481 (2003)Cite this article Accesses. › article

NKTR-102: a new drug for treating platinum-resistant or refractory...

ecancer.org

Professor Ignace Vergote speaks about his research into NKTR-102, a new drug for treating women with platinum-resistant/refractory ovarian cancer. In addition t

NEOADJUVANT CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER Ateş KARATEKE...

slideplayer.com

Extensive and aggressive surgery improve survival The traditional treatment has consisted of PDS and adjuvant chemotherapy The most important factor regarding...

Professor Ignace Vergote: Current perspectives on...

medicines.astrazeneca.be

Inside Diagnostics Professor Ignace Vergote: Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients. Request your free ...

PPT – Ignace Vergote, MD PowerPoint presentation | free to view

www.powershow.com

Recurrent Ovarian Cancer (ROC): Magnitude of the Problem. Patterns of Recurrence ... Delayed time to (symptomatic) disease progression. Markman and ...

Data for: Loss of 1p frequent in low grade serous ovarian...

data.mendeley.com

Supplementary data: processed sequencing data on the 38 low grade serous ovarian cancer samples: place of biopsy, hotspot genotyping by Sequenom, altered...

Ovarian cancer and the immune system - PubMedpubmed.ncbi.nlm.nih.gov › ...

pubmed.ncbi.nlm.nih.gov

Authors. Thaïs Baert , Ignace Vergote , An Coosemans. Affiliations. 1 Department of Gynaecology and Obstetrics, Leuven Cancer Institute, ...Missing: Börm Bruckmeier" Authors. Thaïs Baert , Ignace Vergote , An Coosemans. Affiliations. 1 Department of Gynaecology and Obstetrics, Leuven Cancer Institute, ... Missing: Börm Bruckmeier"

Personen
Vorname "Ignace" (62)
Name "Vergote" (20)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ignace Vergote und Ovarian Person-Info

Ignace Vergote, Novocure Clinical Trial Investigatorwww.novocure.com › Stories

Turabian - AboutScience

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC ...

Dendritic cell-based immunotherapy in ovarian cancer

Standard of care in for patients with ovarian cancer in ...

Psychiatric Times

Least Squares Support Vector Machines - Johan A. K. Suykens, Tony Van...

Neoadjuvant chemotherapy in advanced ovarian cancer

Presentazione standard di PowerPoint - InfoMedics

presentation-tarceva-eortc-asco pdf - ARCAGY

The role of interval debulking surgery in ovarian cancer

NKTR-102: a new drug for treating platinum-resistant or refractory...

NEOADJUVANT CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER Ateş KARATEKE...

Professor Ignace Vergote: Current perspectives on...

PPT – Ignace Vergote, MD PowerPoint presentation | free to view

Data for: Loss of 1p frequent in low grade serous ovarian...

Ovarian cancer and the immune system - PubMedpubmed.ncbi.nlm.nih.gov › ...

Role of IGF-I in Primary Ovarian Cancer - Anticancer Research

EORTC Trial Compares Treatment Options For Patients With Stage...

Neoadjuvant Chemotherapy Recommended for Stage IV Tubo-Ovarian Cancer...

Ovarian cancer and the immune system – topic of research paper in...

Frontline PARP Inhibitors in Ovarian Cancer - Oncology

Incorporation of Pazopanib in Maintenance Therapy of Ovarian ...

Study of Paclitaxel in Patients With Ovarian Cancer - Full Text View...

The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer...

Alle Infos zum Namen "Ignace Vergote"